IVAX Acquisition

February 23, 2006

FAQ on the U.S.Federal Tax Consequences of the Teva/IVAX Merger to Former IVAX Shareholders

January 26, 2006

Teva Completes Acquisition of IVAX

January 25, 2006

Teva Announces Offering of $2.75 Billion of Senior Notes and Convertible Debentures

January 23, 2006

U.S. Federal Trade Commission Clears Teva/IVAX Merger, Closing Scheduled for January 26, 2006

December 22, 2005

Teva and IVAX Sign Consent Order, Schedule Anticipated Closing Date for Merger

December 19, 2005

Teva and IVAX Issue Statement Regarding Elections by Holders of IVAX Convertible Notes

December 6, 2005

Teva Issues Statement Regarding Outstanding IVAX Convertible Notes

November 25, 2005

Teva and IVAX Receive European Commission Approval for Acquisition

October 27, 2005

Teva and Ivax shareholders approve pending merger

October 17, 2005

Teva/Ivax cash and stock election deadline update

September 23, 2005

Teva - Ivax joint proxy statement / prospectus

[PDF 1.02MB]

September 20, 2005

Special Meeting of the shareholders of Teva Pharmaceutical Industries Ltd.

(Hebrew Version)

September 20, 2005

Special Meeting of the shareholders of Teva Pharmaceutical Industries Ltd.

July 26, 2005

Teva - Ivax Luncheon Presentation Webcast

July 25, 2005

Teva-Ivax Conference call

July 25, 2005

Teva to Acquire Ivax for $ 7.4 Billion